# FDA Inspection 958791 - Biogen, Inc. - February 09, 2016

Source: https://www.keypedia.com/records/fda_inspections/biogen-inc/60449a35-5cd2-4d0c-b6cd-96ce8aa597c3
Source feed: FDA_Inspections

> FDA Inspection 958791 for Biogen, Inc. on February 09, 2016. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 958791
- Company Name: Biogen, Inc.
- Inspection Date: 2016-02-09
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1190494 - 2022-11-04](https://www.keypedia.com/records/fda_inspections/biogen-inc/a8e3cb54-bb6a-4cff-8bba-632415562b8c)
- [FDA Inspection 1180550 - 2022-09-02](https://www.keypedia.com/records/fda_inspections/biogen-inc/82230e2a-bb3f-478e-ac66-d4ad9de96473)
- [FDA Inspection 1133055 - 2020-11-10](https://www.keypedia.com/records/fda_inspections/biogen-inc/22d822ad-d609-463f-8c8b-03990b9b04da)
- [FDA Inspection 1130379 - 2020-09-01](https://www.keypedia.com/records/fda_inspections/biogen-inc/2f1b5a81-d499-4309-8375-2da077f63bb2)
- [FDA Inspection 1046583 - 2018-02-13](https://www.keypedia.com/records/fda_inspections/biogen-inc/e4528441-a6d3-46a9-bf79-0ede74540efd)

Company: https://www.keypedia.com/companies/biogen-inc/2cf09880-2ef1-4fb7-9690-fa729e4da5c4

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d